← Leaderboards
Joanne Wuu
University Of Miami School Of Medicine
$7,140,362
Attributed
$14,280,724
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.3M · FY2018–25$20M$15M$10M$5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,280,724 · 2
By mechanism
RF1$11,282,768 · 1
R01$2,997,956 · 1
Top collaborators
- Michael Benatar7 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Ellen F Barrett$2,096,222
- Gavriel David$1,392,301
- Luis E Garcia-Chacon$78,456
Others in their field
Other Emerging Leaders on “Prevention Trial”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Kimberly Smith · Ppd Development Lp$122,008,792
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Yunda Huang · Fred Hutchinson Cancer Center$73,875,286
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
Prevention TrialEnrollmentNatural HistoryPersonsSuperoxide Dismutase 1Follow-UpDisorder PreventionGrantEventNeurodegenerative DisordersGenetic RiskSuccessC9orf72Therapeutic DevelopmentAmyotrophic Lateral SclerosisCohortBiologicalFamilial Amyotrophic Lateral SclerosisBiological MarkersDesignDiagnosisGenesGenetic CounselingFuture
Grant awards (7)
Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention$11,282,768
RF1 · FY2025 · NS
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$549,173
R01 · FY2022 · NS
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$551,711
R01 · FY2021 · NS
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial; Administrative Supplement$171,858
R01 · FY2021 · NS
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$552,712
R01 · FY2020 · NS
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$559,758
R01 · FY2019 · NS
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$612,744
R01 · FY2018 · NS